Loading...
Loading...
Dataset URI:
10.3389/fimmu.2026.1924426.s007BackgroundMethotrexate (MTX)-induced pulmonary fibrosis (MTX-PF) is the most severe and frequently irreversible manifestation of MTX pulmonary toxicity, yet the molecular target and signaling circuitry linking drug exposure to fibrosis remain undefined, hampering diagnosis and targeted intervention.MethodsWe integrated network toxicology, an ensemble of 112 machine-learning classifiers and SHapley Additive exPlanations (SHAP) with six GEO cohorts to nominate fibrotic-lung genes, which were intersected with predicted MTX targets to prioritize candidates relevant to MTX-PF. Lead candidates were validated by molecular docking, 100-ns molecular dynamics simulation, MM-PBSA binding free energy calculation and surface plasmon resonance (SPR). In vivo MTX-induced mouse models and in vitro BEAS-2B assays, including the Transwell migration/invasion, EdU proliferation, immunofluorescence, RT-qPCR, Western blotting, CA4 and TLR4 overexpression, and a CA4/TLR4 co-overexpression rescue experiment, were performed to assess the regulatory role of the top-ranked gene.ResultsCarbonic anhydrase 4 (CA4) ranked first by SHAP importance (0.120) and diagnostic performance (AUC = 0.879); the Ridge model discriminated training and validation cohorts (AUC = 0.930, 0.897 and 0.864). MTX bound stably to CA4 in silico (Vina −7.078 kcal/mol; MM-PBSA ΔGbind −76.5 kJ/mol), and SPR detected concentration-dependent binding to recombinant CA4 (KD = 6.25 μM), identifying CA4 as a candidate direct binding partner. In MTX-treated mice, CA4 was downregulated while TLR4, collagen deposition and serum TNF-α, IL-6, IL-1β, IFN-α and IFN-β were elevated. In BEAS-2B cells, CA4 overexpression suppressed migration, invasion and proliferation, reversed MTX-induced upregulation of TLR4, NF-κB, IRF3, VIM, FN1 and COL1A1, and restored E-cadherin. Forced TLR4 overexpression reversed the protective effect of CA4 and re-established the inflammatory and mesenchymal phenotype.ConclusionIn MTX-PF, MTX directly binds CA4 in vitro. CA4 loss accompanies coordinate upregulation of the TLR4–NF-κB/IRF3 axis and an EMT program coupling epithelial injury to fibrogenesis, and CA4 restoration reverses this program in epithelial cells. Although TLR4 gain-of-function abrogated CA4-mediated suppression, its causal necessity remains untested. Given that TLR4 signaling is context-dependent and can facilitate inflammation resolution in some fibrosis models, therapeutic blockade requires careful attention to cell type and timing. CA4 thus represents a candidate molecular correlate and experimental target, pending clinical and in vivo validation.
Keyword(s):
carbonic anhydrase 4; epithelial-mesenchymal transition; Genetic Immunology; methotrexate-induced pulmonary fibrosis; network toxicology.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)